Patent ID: 7030080

Claim:
A method for treating or lessening the advancement, severity, or effects of neoplasia, comprising administering an effective amount of a composition comprising a pharmaceutically acceptable carrier and a polypeptide complex comprising a first polypeptide selected from a group consisting of (a) a polypeptide comprising the amino acid sequence defined by SEQ ID NO: 2; (b) a polypeptide comprising the amino acid sequence defined by SEQ ID NO: 4; (c) a polypeptide comprising the amino acid sequence defined by SEQ ID NO: 6; (d) a polypeptide comprising the amino acid sequence defined by SEQ ID NO: 2 wherein the amino acids Leu Gly Leu at the amino terminus of said sequence are replaced by a single Met or Leu residue; and a second polypeptide which is lymphotoxin-α.